Litigation Details for Cummisford v. Shire US Inc (D. Wis. 2016)
✉ Email this page to a colleague
Cummisford v. Shire US Inc (D. Wis. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-11-23 |
Court | District Court, E.D. Wisconsin | Date Terminated | 2017-01-20 |
Cause | 15:1 Antitrust Litigation | Assigned To | Pamela Pepper |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,287,599; 6,811,794 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Cummisford v. Shire US Inc
Details for Cummisford v. Shire US Inc (D. Wis. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-11-23 | 1 | method-of-use patent, and U.S. Patent Nos. 6,287,599 (‘599 Patent) and 6,811,794 (‘794 Patent), which cover…Shire’s Intuniv patent portfolio consists of U.S. Patent Nos. 5,854,290 (‘290 Patent), which is a now-invalidated…applied a patent procurement strategy known as “evergreening.” “Evergreened” patents are patents not on …method-of-use patent (‘290 Patent) of guanfacine hydrochloride and two extended release formulation patents (‘599…-of-Use Patent 57. Shire asserted all three (3) patents, including the ‘290 Patent, against | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |